Latest News & Features
Americas
A US district court has dismissed a patent infringement lawsuit between US-based biotechnology company Genzyme and Mylan Pharmaceuticals after the companies agreed to settle. 30 November 2016
Big Pharma
UK life sciences organisations are still uncertain about the implications of Britain’s departure from the EU, despite welcoming the announcement that the UK will ratify the Unified Patent Court Agreement. 30 November 2016
Americas
Nevro, a US-based medical device company, filed a complaint against Boston Scientific yesterday in a US district court for allegedly infringing patents covering Nevro’s spinal cord stimulation therapy. 29 November 2016
Africa
Mylan has entered into a sub-licensing agreement with the Medicines Patent Pool, a UN-backed public health organisation, to expand access to chronic hepatitis C medicines in developing countries. 29 November 2016
Big Pharma
The market for counterfeit pharmaceuticals is worth $200 billion a year, beating almost everything else in the underground economy, including prostitution, human trafficking and illegal arms sales. 28 November 2016
Big Pharma
The English High Court has ruled in favour of Merck Sharp & Dohme (MSD) in a patent battle against Shionogi, over Merck’s product Isentress. 28 November 2016
Americas
AstraZeneca and Acorda have asked the US Supreme Court not to hear an appeal from Mylan challenging a Federal Circuit ruling. 25 November 2016
Americas
Novartis has acquired Selexys Pharmaceuticals Corporation, a company specialising in the development of therapeutics in certain hematologic and inflammatory disorders. 25 November 2016
Americas
A California district court has dismissed a lawsuit filed by The Scripps Research Institute, a US non-profit medical research facility, against biotechnology company Illumina for alleged patent infringement. 24 November 2016
Asia
India-based drugs company Sun Pharma has agreed to acquire Russia-based pharmaceutical business Biosintez. 24 November 2016